Evidence map›Paper›PMID 33968955›Full record

ArticleFrontiers in medicine2021

Production of Mass-Separated Erbium-169 Towards the First Preclinical

Zeynep Talip, Francesca Borgna, Cristina Müller, Jiri Ulrich, Charlotte Duchemin, Joao P Ramos, Thierry Stora, Ulli Köster, Youcef Nedjadi, Vadim Gadelshin and 12 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Selective isotope separation ofScientific reports · 2026
    Article
  2. Laser isotope enrichment ofScientific reports · 2025
    Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 7 institutions in 5 countries.

Zeynep TalipCenter for Radiopharmaceutical Sciences ETH-PSI-USZ, Paul Scherrer Institute, Villigen, Switzerland.
Francesca BorgnaCenter for Radiopharmaceutical Sciences ETH-PSI-USZ, Paul Scherrer Institute, Villigen, Switzerland.
Cristina MüllerCenter for Radiopharmaceutical Sciences ETH-PSI-USZ, Paul Scherrer Institute, Villigen, Switzerland.
Jiri UlrichLaboratory of Radiochemistry, Paul Scherrer Institute, Villigen, Switzerland.
Charlotte DucheminEuropean Organization for Nuclear Research (CERN), Geneva, Switzerland.
Joao P RamosEuropean Organization for Nuclear Research (CERN), Geneva, Switzerland.
Thierry StoraEuropean Organization for Nuclear Research (CERN), Geneva, Switzerland.
Ulli KösterInstitut Laue-Langevin, Grenoble, France.
Youcef NedjadiInstitute of Radiation Physics, University Hospital and University of Lausanne, Lausanne, Switzerland.
Vadim GadelshinEuropean Organization for Nuclear Research (CERN), Geneva, Switzerland.
Valentin N FedosseevEuropean Organization for Nuclear Research (CERN), Geneva, Switzerland.
Frederic JugetInstitute of Radiation Physics, University Hospital and University of Lausanne, Lausanne, Switzerland.
Claude BailatInstitute of Radiation Physics, University Hospital and University of Lausanne, Lausanne, Switzerland.
Adelheid FankhauserAnalytic Radioactive Materials, Paul Scherrer Institute, Villigen, Switzerland.
Shane G WilkinsEuropean Organization for Nuclear Research (CERN), Geneva, Switzerland.
Laura LambertEuropean Organization for Nuclear Research (CERN), Geneva, Switzerland.
Bruce MarshEuropean Organization for Nuclear Research (CERN), Geneva, Switzerland.
Dmitry FedorovPetersburg Nuclear Physics Institute, National Research Center Kurchatov Institute, Gatchina, Russia.
Eric ChevallayEuropean Organization for Nuclear Research (CERN), Geneva, Switzerland.
Pascal FernierEuropean Organization for Nuclear Research (CERN), Geneva, Switzerland.
Roger SchibliCenter for Radiopharmaceutical Sciences ETH-PSI-USZ, Paul Scherrer Institute, Villigen, Switzerland.
Nicholas P van der MeulenCenter for Radiopharmaceutical Sciences ETH-PSI-USZ, Paul Scherrer Institute, Villigen, Switzerland.
European Organization for Nuclear Research · CHPaul Scherrer Institute · CHUniversity of Lausanne · CHInstitut Laue-Langevin · FRKU Leuven · BEPetersburg Nuclear Physics Institute · RUUral Federal University · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The β

Indexed as

activity standardizationelectromagnetic isotope separationEr-169in vitro studieslanthanide-separationlaser resonance ionization

Identifiers

PMID33968955
PMCPMC8100037
OpenAlexW3157929989

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.